0.5940
0.0000
(0.00%)
At close: January 30 at 9:59:02 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 4 | 4 |
| Avg. Estimate | 5.42M | 4.69M | 21.41M | 20.32M |
| Low Estimate | 3.38M | 3.38M | 19.36M | 14.59M |
| High Estimate | 8M | 6M | 24M | 25M |
| Year Ago Sales | 4.29M | 3.4M | 14.92M | 21.41M |
| Sales Growth (year/est) | 26.40% | 38.14% | 43.48% | -5.06% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| W2J.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 1/17/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/13/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/16/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 12/12/2024 |
| Downgrade | Baird: Outperform to Neutral | 12/12/2024 |
| Downgrade | Evercore ISI Group: Outperform to In-Line | 12/11/2024 |
Related Tickers
YAG2.F Atossa Therapeutics, Inc.
0.8510
+21.57%
2X10.F ABIVAX Société Anonyme
5.55
+0.91%
BX2.F BioXcel Therapeutics, Inc.
0.3289
+10.00%
PSH.F Sernova Corp.
0.1363
+0.22%
W1H.F Onco-Innovations Limited
1.3300
+2.31%
IFRX InflaRx N.V.
2.4100
+1.69%
ATOS Atossa Therapeutics, Inc.
0.8419
-2.70%
PPCB Propanc Biopharma, Inc.
9.00
0.00%
MRNA Moderna, Inc.
39.42
-3.95%